NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Chronic hepatitis C
Date of first enrollment	01/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Peginterferon alpha-2a|ribavirin INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administration for Investigational material : Peginterferon alpha-2a: Subcutaneous injection Ribavirin: Oral

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Male and female patients and over 20 years of ages with CHC, elevated ALT and detectable HCV RNA.
Exclude criteria